Share on:
Mobelife and JRI Orthopaedics will collaborate to grow Mobelife’s aMace® Acetabular Revision System business further in the UK and Ireland. aMace is designed to offer complete personalization to both patient and surgeon.
Mobelife’s solution for hip revisions will join JRI’s lower limb portfolio, a range of implants and instruments including the Furlong hip stem. Mobelife, part of the Materialise Group, offers a completely customized product development process for patient-specific orthopaedic implants.
Source: Mobelife NV
RELATED ARTICLES
Janco Medical to Focus on Packaging and Cleanroom Manufacturing
Apr 10 2024 , Julie A. Vetalice
Evonik Grows Capacity for Customized RESOMER Powder Biomaterials
Apr 10 2024 , Julie A. Vetalice
Exploring Why Automation Leads to Improved Medical Device Manufacturing
Apr 09 2024 , Lowell
FDA De Novo for Orthobond’s Ostaguard Antibacterial Surface Treatment
Apr 08 2024 , Julie A. Vetalice